ZenithTX2 TAA Endovascular Graft Post-approval Study
The Zenith TX2 Post-market Approval Study is a clinical trial approved by US FDA to further study the safety and effectiveness of the Zenith TX2 TAA Endovascular Graft in the treatment of thoracic aortic aneurysms.
Keywordssafety, endovascular graft, thoracic aortic, aneurysms
Principal InvestigatorAdam W Beck, M.D.
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.